Miller, Paul D.

Effect of Risedronate on the Risk of Hip Fracture in Elderly Women

McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., et al. (2001) · New England Journal of Medicine

Bone health and osteoporosis researchHip and Femur Fractures

Cited by 1,918

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study

Chesnut, C. H., Silverman, S., Andriano, K., Genant, H., Gimona, A., Harris, S., Kiel, D., LeBoff, M., Maricic, M., Miller, P., et al. (2000) · The American Journal of Medicine

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 1,122

Monthly Oral Ibandronate Therapy in Postmenopausal Osteoporosis: 1-Year Results From the MOBILE Study

Miller, P. D., Mcclung, M. R., Macovei, L., Stakkestad, J. A., Luckey, M., Bonvoisin, B., Reginster, J.-Y., Recker, R. R., Hughes, C., Lewiecki, E. M., et al. (2005) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchBone health and treatments

Cited by 333

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

Reginster, J.-Y., Adami, S., Lakatos, P., Greenwald, M., Stepan, J. J., Silverman, S. L., Christiansen, C., Rowell, L., Mairon, N., Bonvoisin, B., et al. (2006) · Annals of the Rheumatic Diseases

Bone health and osteoporosis researchBone health and treatments

Cited by 326

The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50–99: results from the National Osteoporosis Risk Assessment (NORA)

Siris, E. S., Brenneman, S. K., Barrett-Connor, E., Miller, P. D., Sajjan, S., Berger, M. L., & Chen, Y.-T. (2006) · Osteoporosis International

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 270